Explore Watchlists Pricing

VERTEX PHARMACEUTICALS INC (VRTX) Balance sheet

Market cap

$111.4B

P/E ratio

28.6x

Summary Financials

Income statement Balance sheet Cash flow Other

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	243	475	489	569	625	715	1,184	1,665	2,658	3,121	5,989	6,800	10,512	10,372	4,572	5,088
Total cash & short-term investments	243	475	489	569	625	715	1,184	1,665	2,658	3,121	5,989	6,800	10,512	10,372	4,572	5,088
Accounts receivable, net	13	183	143	86	76	178	201	281	410	634	885	1,137	1,442	1,563	1,609	2,053
Inventories	-	112	30	14	31	57	78	112	124	168	281	353	461	739	1,205	1,687
Total current assets	1,057	1,331	1,590	1,589	1,547	1,407	1,832	2,649	3,843	4,823	8,133	9,561	13,235	14,144	9,596	11,201
Property, plant and equipment, net	72	133	434	697	716	698	698	789	812	-	-	-	-	-	-	-
Marketable securities, non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	2,498	5,108	5,712
Total non-current assets	-	-	-	-	-	-	-	-	-	833	1,284	1,424	1,456	1,453	2,585	3,083
Total assets	1,725	2,204	2,759	2,319	2,335	2,499	2,897	3,546	6,246	8,318	11,752	13,433	18,151	22,730	22,533	25,643
Accounts payable	36	75	101	49	71	75	61	74	111	88	155	195	304	365	413	462
Total current liabilities	475	392	433	398	368	506	793	807	1,120	1,335	1,878	2,142	2,742	3,547	3,565	3,861
Total liabilities	1,221	1,239	1,525	963	1,238	1,405	1,559	1,504	1,811	2,233	3,065	3,333	4,238	5,150	6,124	6,977
Retained earnings	-3,444	-3,415	-3,522	-3,967	-4,705	-5,262	-5,374	-5,120	-2,989	-1,853	859	3,201	6,523	10,142	9,607	13,560
Stockholders' equity	504	928	1,196	1,356	1,096	1,094	1,338	2,042	4,435	6,085	8,687	10,100	13,913	17,580	16,410	18,666
Working capital	-